For citations:

Kolyadina I.V. 10 years of success achieved by eribulin while treating HER2-negative mBC: from randomized studies to routine practice. Tumors of female reproductive system. 2021;17(3):59-68. https://doi.org/10.17650/1994-4098-2021-17-3-59-68